Shinva Medical Instrument Co Ltd
SSE:600587
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| CN |
|
Shinva Medical Instrument Co Ltd
SSE:600587
|
9.4B CNY |
Loading...
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
192B USD |
Loading...
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
174.6B USD |
Loading...
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
136.5B USD |
Loading...
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
131.8B USD |
Loading...
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
112.1B USD |
Loading...
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
59.8B USD |
Loading...
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
46B EUR |
Loading...
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
51.6B USD |
Loading...
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
45.4B USD |
Loading...
|
|
| US |
|
Resmed Inc
NYSE:RMD
|
39.5B USD |
Loading...
|
Market Distribution
| Min | -416 945.9% |
| 30th Percentile | -1.5% |
| Median | 3.5% |
| 70th Percentile | 8.9% |
| Max | 17 382.1% |
Other Profitability Ratios
Shinva Medical Instrument Co Ltd
Glance View
In the brisk hustle of China's healthcare evolution, Shinva Medical Instrument Co., Ltd. stands as a pivotal player, navigating the intricate world of medical devices and pharmaceutical machinery since its inception in 1943. Rooted deeply in the tangible yet transformative realm of healthcare technology, Shinva has advanced from its initial focus on producing pharmaceutical sterilization equipment to a comprehensive provider of medical solutions. With its headquarters in the tech-driven province of Shandong, Shinva operates in various sectors, providing a multifaceted approach to healthcare. The company’s operations span across diverse segments including medical devices, environmental protection equipment, and pharmaceutical engineering services, ensuring it remains adaptive to contemporary medical demands and regulatory standards. Revenue flows primarily from the design, manufacture, and distribution of medical and laboratory equipment, widening its customer base from local hospitals to international healthcare facilities. Shinva’s portfolio is intriguingly broad, encompassing products that range from high-end sterilization tools and radiation therapy equipment to diagnostic imaging and surgical instruments. This diversification safeguards the company against market volatility while aligning with the ever-increasing demand for efficiency and safety in medical procedures. Moreover, its commitment to research and development underscores its strategic mission to innovate and refine healthcare delivery systems, anchoring its status as a leader in the industry. This adaptability and relentless pursuit of quality enable Shinva to thrive, aptly positioning it to grow alongside China's expansive healthcare sector.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Shinva Medical Instrument Co Ltd is 5.3%, which is below its 3-year median of 6.4%.
Over the last 3 years, Shinva Medical Instrument Co Ltd’s Net Margin has decreased from 6.1% to 5.3%. During this period, it reached a low of 5.3% on Oct 30, 2025 and a high of 6.9% on Dec 31, 2024.